Scarica l'app Stockscreener
0.072
9.84%
0.00645
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché BACK Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.0656
Aprire:
$0.06645
Volume 24 ore:
3,720
Relative Volume:
1.29
Capitalizzazione di mercato:
$N/A
Reddito:
$57,800
Utile/perdita netta:
$-8.76M
Rapporto P/E:
-0.0105
EPS:
-6.8367
Flusso di cassa netto:
$-4.56M
1 W Prestazione:
-9.89%
1M Prestazione:
-10.00%
6M Prestazione:
-95.77%
1 anno Prestazione:
-98.38%
Intervallo 1D:
$0.0665
$0.072
Intervallo di 1 settimana:
$0.061
$0.08
Portata 52W:
$0.0368
$0.088
Imac Holdings Inc Stock (BACK) Company Profile
Nome
Imac Holdings Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta BACK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BACK
Imac Holdings Inc
|
0.072 | 0 | 57,800 | -8.76M | -4.56M | -6.8367 |
|
HCA
Hca Healthcare Inc
|
467.86 | 104.60B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
216.17 | 18.59B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
27.20 | 15.99B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
EHC
Encompass Health Corp
|
127.18 | 12.70B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
214.03 | 13.41B | 16.08B | 1.20B | 1.06B | 17.82 |
Imac Holdings Inc Borsa (BACK) Ultime notizie
IMAC Holdings Issues Unsecured Promissory Note - MSN
IMAC (BACK) raises $144,000 via unsecured $201,600 note - Stock Titan
IMAC Holdings, Inc. announced that it has received $0.144 million in funding - MarketScreener
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating IMAC Holdings, Inc. Merger - 富途牛牛
IMAC Holdings, Inc. announced that it has received $0.212 million in funding - MarketScreener
IMAC Holdings Issues Promissory Note Amid Board Changes - TipRanks
Ignite Proteomics Announces Collaboration with Inova Health on a Biomarker Study for Late-Stage Cancers - GlobeNewswire
600 Late-Stage Cancer Patients: Ignite Proteomics Launches Groundbreaking Precision Treatment Study - Stock Titan
IMAC Holdings Announces Research Collaboration with - GlobeNewswire
Cancer Research Breakthrough: IMAC-Vanderbilt Alliance Targets New Breast Cancer Treatment Markers - Stock Titan
IMAC Holdings Announces Research Collaboration with Vanderbilt U - GuruFocus
IMAC Holdings Announces Research Collaboration with Vanderbilt University Medical Center to Advance Immuno-Oncology Biomarker Discovery - Yahoo Finance
Delisting of Securities from The Nasdaq Stock Market - The Manila Times
Nasdaq Announces Delisting of Multiple Companies Including NKGen Biotech, Aquaron Acquisition Corp, and Others - Quiver Quantitative
Allarity Therapeutics appoints Jeffrey S. Ervin as part-time chief financial officer - Investing.com Nigeria
Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer - The Manila Times
Former NYSE Executive Takes CFO Role at Cancer Drug Developer Allarity Therapeutics - Stock Titan
Imac Holdings Issues Unsecured Promissory Note - TipRanks
Form 10-KAnnual Reports - Stock Titan
Is IMAC Holdings, Inc. overvalued or undervalued? - MarketsMojo
IMAC Holdings Issues Promissory Note for $301,000 - TipRanks
IMAC Holdings Appoints New Board Members for Strategic Growth - TipRanks
IMAC Holdings Issues Promissory Note for $455,000 - TipRanks
HCA Healthcare (HCA) Stock Drops 5% Amid Industry Decline - GuruFocus
IMAC Holdings Delays Q1 2025 Report Filing - TipRanks
IMAC Holdings Issues Promissory Note for $275,800 - TipRanks
United States shares lower at close of trade; Dow Jones Industrial Average down 0.31% - Investing.com India
Local company faces delisting | Area Stocks - Nashville Post
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.31% - Investing.com
US Stocks Mixed; Core & Main Posts Downbeat Earnings - Benzinga
IMAC Holdings delisted from the Nasdaq, looking to listing elsewhere - The Business Journals
Imac Holdings investor Jorge Ruiz sells $15,000 in stock By Investing.com - Investing.com
IMAC Holdings violated another Nasdaq listing rule - The Business Journals
Ignite Proteomics to Present Data on MHC-II as a Predictor of Pembrolizumab Response at NCCN Annual Conference - Yahoo Finance
Ignite Proteomics LLC Completes Transfer of PLA Code 0249U to Enhance Breast Cancer Diagnostic Capabilities - Nasdaq
IMAC Holdings to appeal Nasdaq delisting ruling - The Business Journals
IMAC Holdings Announces Proxy Statement Filing and NASDAQ Appeal - Investing.com
XETRA Trading Companies List - Morningstar
Ignite Proteomics Announces Publication of Study Demonstrating Superiority of Protein Activation Analysis in Predicting Breast Cancer Therapy Response - GlobeNewswire
US Stocks Mixed; General Dynamics Earnings Top Views - Benzinga
Is BACK Making a Comeback? - StocksToTrade
IMAC Holdings Launches Ignite Proteomics to Revolutionize Cancer Treatment Selection with Protein-Level Insights - Quiver Quantitative
IMAC Holdings faces Nasdaq delisting over equity shortfall - Investing.com
IMAC Holdings regains Nasdaq compliance for one of two infractions - The Business Journals
IMAC Holdings regains Nasdaq compliance with audit committee requirements - Investing.com
IMAC Holdings receives another strike from Nasdaq - The Business Journals
IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q - GlobeNewswire
IMAC lands delisting deadline extension - Nashville Post
IMAC Holdings Granted Extension by Nasdaq to Regain Compliance with Listing Rule 5250(c)(1) - GlobeNewswire
Brookdale Senior Living (BKD) Sees Stock Surge Amid Mixed Analys - GuruFocus
IMAC Holdings welcomes Jeffrey Busch to its Board of Directors - Investing.com
Imac Holdings Inc Azioni (BACK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.44%
0.25%
Capitalizzazione:
|
Volume (24 ore):